Alira Health

Alira Health

Increasing Access to Genomic Testing in Europe

The role of national genomic initiatives in increasing uptake of Advanced Diagnostics

What are the measures that leading EU Member States have taken to pave the way toward wider access to genomic testing? Last month, Richard Charter, our Vice President MedTech Market Access – Europe & Asia Pacific, joined the podcast by EUCOPE – European Confederation of Pharmaceutical Entrepreneurs to discuss what else can be done to ensure that genomic testing becomes accessible to the patients.

Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics” below:

The episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics” is also available on the following platforms:

Google Podcasts    Pocket Casts    RadioPublic   Spotify

Meet the guests of this episode:
Published on:
June 21, 2022
Richard Charter

Richard Charter

Vice President MedTech Market Access - Europe & Asia Pacific, Alira Health Richard Charter has 15 years of experience in financial economics, health economics, consulting, market access, and pricing for MedTech companies. Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare.
Caroline van der Meijden

Caroline van der Meijden

Director of Reimbursement EU, Agendia As an extension of her PhD in life sciences Caroline van der Meijden is an expert in Health Technology Assessment (HTA) with experience in both public and private sectors. Agendia is a global leader in innovative genomic technology and diagnostic tests for breast cancer.
Don Husereau

Don Husereau

Health Economist & Adjunct Professor at the University of Ottawa Don Husereau does freelance health care research, and works with private and public sector life sciences organizations to help them understand the value of health technology and its implications for health and innovation policy.
Matias Olsen

Matias Olsen

Public Affairs and Policy Manager at EUCOPE Matias Olsen supports EUCOPE on key topics, covering among others, EU HTA, advanced diagnostics, the Pharmaceutical Strategy, EU’s cancer plan, blood, tissues and cells legislation and relevant market access topics. He coordinates members’ thematic working groups, including the P&R/Market Access Working Group, the Genomics Working Group and the EU HTA Regulation Task Force.

Would you like to learn more about Advanced Diagnostics? Check out the episode of our podcast Transformation Talks “An Advanced Perspective on Advanced Diagnostics”!

Related news

Reports May 20, 2024
Innovative Payment Schemes for Medtech in England, Germany, and France
This overview offers high-level details on the innovative payment schemes in England, Germany, and France.
Case Studies May 14, 2024
Medtech Company Creates an Early Go-to-Market Strategy for Its Breakthrough IVD Solution
The client needed an early go-to-market strategy for their IVD solution to prepare for product development and launch in key European countries and the US.
IVDR Medical Devices MedTech
Case Studies May 8, 2024
Mid-Size Medtech Company with a Borderline Product Defines Strategy for EU Launch
Medtech company sought support in developing a regulatory strategy for the EU launch of their product with an aggressive timeline to launch.
Medical Devices MedTech Regulatory
Reports May 8, 2024
Value-Based Procurement in Australia
This white paper discusses why value-based healthcare and procurement are solutions in a robust healthcare system and identifies the medical technology sector as a collaborative partner(...)
MedTech Value-Based Contracts
Case Studies April 30, 2024
Medtech Company Leverages Bayesian Clinical Trial Design to Address FDA Feedback
A global medtech company needed help to address FDA feedback on their implant design that included a comparator and clearly demonstrated the safety and performance of this new device.
Clinical Trials Complex Innovative Design MedTech
Events April 30, 2024
The MedTech Forum 2024
We are thrilled to announce that we will exhibit and speak at The MedTech Forum 2024.
MedTech Regulatory
News April 29, 2024
Alira Health Advises Trill Impact Entering a Strategic Alliance with TT medic
We are pleased to have been a Commercial Due Diligence advisor for Trill Impact, a pioneering Impact House with around EUR 1.2 billion in assets under management, joining forces with(...)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.